| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 4 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 3 | ADALIMUMAB | 3 |
| 4 | BLINATUMOMAB | 3 |
| 5 | NIVOLUMAB | 3 |
| 6 | ACYCLOVIR | 2 |
| 7 | ALEMTUZUMAB | 2 |
| 8 | ASPIRIN | 2 |
| 9 | ASPIRIN 325 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 1 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 2 | TAFASITAMAB-CXIX | 1 | 0.0011 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 5 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| 6 | BLINATUMOMAB | 3 | 0.0003 |
| 7 | CARMUSTINE | 1 | 0.0002 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 2 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 3 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 8 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |